Notice of Allowance Issued for Central Nervous System Peptide Technology

You probably know that psilocybin can help cancer patients with end-of-life anxiety, but it’s now being used to help with other side effects of cancer too.

Late stage cancer patients often experience a condition called cachexia, which causes loss of appetite, extreme weight loss and muscle wasting. AIkido Pharma Inc. (AIKI), a New York based company, is working to treat cancer cachexia with psilocybin. Psilocybin may be able to treat cachexia by reducing neuroinflammation in the brain and central nervous system tissues. AIkido Pharma was recently granted an exclusive sublicense to use homing peptide technology to deliver therapeutic agents to inflamed central nervous system tissue.